For-profit telemarketers operating in New York kept 62 percent of the $249 million in charitable donations they raised in 2012, New York Attorney General Eric Schneiderman’s office said in a report on charity fundraising that may lead to further investigations.
Eli Lilly & Co.’s experimental drug dulaglutide was as good at controlling Type 2 diabetes as the leading treatment in a clinical trial, providing Lilly with a potential marketing advantage as it seeks to gain approval of the medicine.
Carol Patterson was waiting for a call from her doctor. When the phone rang on that afternoon in August 2011 at her home in Cortland, Ohio, it wasn’t a physician on the other end. A woman named Robin said she was representing the American Diabetes Association.
Merck & Co., Novo Nordisk A/S and other makers of popular treatments for diabetes may be asked to collect more data on a potential cancer link even as they try to reassure U.S. regulators this week of the drugs’ safety.
An 80-year-old drug used to protect people against tuberculosis may help reverse Type 1 diabetes, the most severe form of the disease, in patients who have had it for years, an early study in six patients found.
Aug. 30 (Bloomberg) -- An InfoCision representative calls a prospective volunteer to ask them to participate in a mailing campaign to solicit funds for the American Diabetes Association. (Source: Bloomberg)